Translating Science into Medicines - helping innovative companies grow from scientific foundations to advance clinical development of meaningful medicines in development-stage biotechnology
| Firm Name | Ascenta Capital |
| Investment Thesis/Focus | Translating Science into Medicines - helping innovative companies grow from scientific foundations to advance clinical development of meaningful medicines in development-stage biotechnology |
| Location (City/State) | West Palm Beach, Florida |
| Year Founded | 2023 |
| Number of Team Members (partners/investors) | 11 |
| Investment Stage/Check Sizes | Development-stage biotech (Phase 1 and 2 clinical; check sizes $15-30M; $335M AUM) |
| Founding/Managing Partners | Evan Rachlin, MD and Lorence Kim, MD (Co-Founders, Managing Partners; both former Moderna executives) |
| Business Entity Type | Not found in public records (WHOIS/search blocked by captchas; state registry interface only) |
| Public Email (firm domain) | info@ascentacap.com |